Literature DB >> 30917024

Comparison of Iodine Quantification and Conventional Attenuation Measurements for Differentiating Small, Truly Enhancing Renal Masses From High-Attenuation Nonenhancing Renal Lesions With Dual-Energy CT.

Mathias Meyer1,2, Rendon C Nelson, Federica Vernuccio1,3, Fernando Gonzalez1,4, Christoph Schabel1,5, Achille Mileto, Bhavik N Patel, Stefan O Schoenberg, Daniele Marin.   

Abstract

OBJECTIVE. The purpose of this study is to determine whether iodine quantification techniques from contrast-enhanced dual-energy CT (DECT) data allow equal differentiation of small enhancing renal masses from high-attenuation (> 20 HU of unenhanced attenuation) nonenhancing lesions, compared with conventional attenuation measurements. MATERIALS AND METHODS. A total of 220 nonconsecutive patients (mean [± SD] age, 66 ± 13 years; 130 men and 90 women) with 265 high-attenuation renal lesions (mean attenuation, 54 ± 33 HU; 91 enhancing lesions) were included. Each patient underwent single-energy unenhanced CT followed by DECT during the nephrographic phase using one of four different high-end DECT platforms (first- and second-generation rapid-kilovoltage-switching DECT platforms and second- and third-generation dual-source DECT platforms). Iodine quantification measurements and conventional attenuation change measurements were calculated for each lesion. Diagnostic accuracy was determined by pathologic analysis, confirmation with another imaging modality, or greater than 24 months of imaging follow-up as the reference standard. RESULTS. The diagnostic accuracy for differentiating enhancing from nonenhancing renal lesions was significantly higher for conventional attenuation change measurements, compared with iodine quantification measurements (AUC values, 0.973 vs 0.875; p < 0.0001). The diagnostic performance of iodine quantification measurements improved only marginally with the utilization of DECT platform-specific optimized iodine quantification thresholds, yielding AUC values of 0.907 and 0.893 for the rapid-kilovoltage-switching DECT and dual-source DECT platforms, respectively. Unenhanced lesion attenuation (p = 0.0010) and intraparenchymal location (p = 0.0249) significantly influenced the diagnostic accuracy of the iodine quantification techniques. CONCLUSION. Iodine quantification from DECT data yields inferior diagnostic accuracy when compared with conventional attenuation change measurements for differentiating small, truly enhancing renal masses and high-attenuation renal lesions.

Entities:  

Keywords:  dual energy; enhancement; iodine quantification; renal lesion

Year:  2019        PMID: 30917024     DOI: 10.2214/AJR.18.20547

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

Review 1.  Use of dual-energy CT for renal mass assessment.

Authors:  Shanigarn Thiravit; Christina Brunnquell; Larry M Cai; Mena Flemon; Achille Mileto
Journal:  Eur Radiol       Date:  2020-11-18       Impact factor: 5.315

2.  Iodine quantification and detectability thresholds among major dual-energy CT platforms.

Authors:  Ross Edward Taylor; Pamela Mager; Nam C Yu; David P Katz; Jett R Brady; Nakul Gupta
Journal:  Br J Radiol       Date:  2019-10-07       Impact factor: 3.039

3.  Dual-Energy CT Images: Pearls and Pitfalls.

Authors:  Anushri Parakh; Simon Lennartz; Chansik An; Prabhakar Rajiah; Benjamin M Yeh; Frank J Simeone; Dushyant V Sahani; Avinash R Kambadakone
Journal:  Radiographics       Date:  2021 Jan-Feb       Impact factor: 5.333

4.  Diagnostic performance of single-phase dual-energy CT to differentiate vascular and nonvascular incidental renal lesions on portal venous phase: comparison with CT.

Authors:  Domenico Mastrodicasa; Martin J Willemink; Nikhil Madhuripan; Ranjit Singh Chima; Amanzo A Ho; Yuqin Ding; Daniele Marin; Bhavik N Patel
Journal:  Eur Radiol       Date:  2021-06-11       Impact factor: 7.034

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.